CJC-1295 and ipamorelin: the science of a growth hormone peptide stack
CJC-1295 and ipamorelin are two growth hormone peptides often prescribed together because they raise growth hormone through two complementary pathways. This guide explains what each one is, how they work as a pair, what the research does and does not yet show, and how a provider prescribes and monitors them.
What are CJC-1295 and ipamorelin?
CJC-1295 is a long-acting analog of growth hormone releasing hormone (GHRH). It tells the pituitary to release growth hormone, and its modifications make that signal last longer. Ipamorelin is a selective growth hormone secretagogue that works through a different receptor (the ghrelin or GH secretagogue receptor), giving the pituitary a second, complementary nudge.
Used together, they raise growth hormone through two pathways at once while aiming to preserve the body's natural, pulsing release. Both are unapproved, compounded peptides.
At Expert Health, CJC-1295 and ipamorelin are prescribed by a US-licensed provider and compounded by an FDA-regulated pharmacy. These are not FDA-approved medications. See the disclaimer below.
How the combination works
The two peptides are paired because they act on different receptors. CJC-1295 increases the amount of growth hormone released, while ipamorelin increases the number of release pulses, and ipamorelin is considered selective, meaning it has little effect on other hormones like cortisol.
- CJC-1295 extends and raises the growth hormone signal (GHRH pathway).
- Ipamorelin adds selective pulses through the ghrelin receptor pathway.
- Together, they aim to support lean mass, recovery, and sleep while keeping natural feedback.
What the research does and doesn't show
There is real human data that CJC-1295 raises growth hormone and IGF-1. In a published trial (Teichman and colleagues, Journal of Clinical Endocrinology & Metabolism, 2006), a single dose raised growth hormone several-fold and IGF-1 for up to two weeks, with growth hormone pulses preserved and no serious adverse events.
What is far less established are the long-term, real-world outcomes people are usually after, like body composition and recovery, especially for the combination over time. The honest framing is that the hormone effect is real and the rationale is sound, while broad long-term benefit claims should be treated with caution. That is why provider oversight matters.
Who it's for
This combination is a provider-guided option for adults exploring growth hormone support for muscle, recovery, or healthy aging. A provider reviews your history and labs and confirms it is appropriate. It is not right for everyone, including people with active cancer or certain other conditions.
Safety and side effects
Reported side effects are usually mild and include injection site reactions, flushing, headache, and water retention. Because these peptides raise growth hormone activity, provider screening and monitoring matter, which is why this should never be a gray-market purchase.
Frequently asked questions
Why are CJC-1295 and ipamorelin used together?
Are they FDA approved?
How are they taken?
Sources
- Teichman SL, et al. Prolonged Stimulation of GH and IGF-1 Secretion by CJC-1295, a Long-Acting Analog of GHRH, in Healthy Adults · Journal of Clinical Endocrinology & Metabolism, 2006
- Activation of the GH/IGF-1 axis by CJC-1295 in normal adult subjects · PMC / National Library of Medicine
This article is for educational purposes and is not medical advice. Statements have not been evaluated by the FDA, and this treatment is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved. Individual results vary. Always consult a licensed provider before starting any treatment.
Explore other muscle and recovery options.
Ready to see if CJC-1295 / Ipamorelin is right for you?
Book a free, no-obligation consult. A US-licensed provider reviews your goals and history and tells you straight, no pressure either way.
See if I qualify